AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,414 | -65.3% | 121,416 | -72.2% | 0.00% | -100.0% |
| Q2 2023 | $399,186 | +4557.4% | 436,269 | +2836.8% | 0.00% | – |
| Q4 2022 | $8,571 | -87.0% | 14,855 | -92.9% | 0.00% | – |
| Q3 2022 | $66,000 | -68.7% | 209,755 | -64.9% | 0.00% | -100.0% |
| Q2 2022 | $211,000 | +33.5% | 598,379 | +1339.7% | 0.00% | 0.0% |
| Q2 2021 | $158,000 | -46.3% | 41,564 | +92.3% | 0.00% | -50.0% |
| Q2 2020 | $294,000 | – | 21,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |